Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1905 1
1907 1
1910 1
1911 1
1918 1
1920 1
1921 1
1923 1
1938 1
1950 2
1959 1
1967 1
1972 2
1973 2
1974 3
1975 1
1976 1
1978 2
1979 3
1980 8
1981 4
1982 4
1983 10
1984 7
1985 5
1986 11
1987 8
1988 10
1989 8
1990 10
1991 3
1992 9
1993 4
1994 14
1995 10
1996 14
1997 9
1998 14
1999 12
2000 20
2001 27
2002 15
2003 14
2004 24
2005 18
2006 27
2007 31
2008 26
2009 22
2010 29
2011 39
2012 63
2013 46
2014 57
2015 79
2016 86
2017 56
2018 67
2019 56
2020 36
2021 64
2022 40
2023 53
2024 42

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,139 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence, Predictors, and Treatment of Impostor Syndrome: a Systematic Review.
Bravata DM, Watts SA, Keefer AL, Madhusudhan DK, Taylor KT, Clark DM, Nelson RS, Cokley KO, Hagg HK. Bravata DM, et al. Among authors: watts sa. J Gen Intern Med. 2020 Apr;35(4):1252-1275. doi: 10.1007/s11606-019-05364-1. Epub 2019 Dec 17. J Gen Intern Med. 2020. PMID: 31848865 Free PMC article. Review.
Introduction to THOR supplement.
Woolley T, Yazer M, Watts S. Woolley T, et al. Among authors: watts s. Transfusion. 2021 Jul;61 Suppl 1:S1. doi: 10.1111/trf.16533. Transfusion. 2021. PMID: 34269442 No abstract available.
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2).
Fleischmann RM, van der Heijde D, Strand V, Atsumi T, McInnes IB, Takeuchi T, Taylor PC, Bracher M, Brooks D, Davies J, Goode C, Gupta A, Mukherjee S, O'Shea C, Saurigny D, Schifano LA, Shelton C, Smith JE, Wang M, Wang R, Watts S, Weinblatt ME. Fleischmann RM, et al. Among authors: watts s. Ann Rheum Dis. 2023 Dec;82(12):1516-1526. doi: 10.1136/ard-2023-224482. Epub 2023 Sep 12. Ann Rheum Dis. 2023. PMID: 37699654 Free PMC article. Clinical Trial.
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3).
Taylor PC, Weinblatt ME, McInnes IB, Atsumi T, Strand V, Takeuchi T, Bracher M, Brooks D, Davies J, Goode C, Gupta A, Mukherjee S, O'Shea C, Saurigny D, Schifano LA, Shelton C, Smith JE, Wang M, Wang R, Watts S, Fleischmann RM. Taylor PC, et al. Among authors: watts s. Ann Rheum Dis. 2023 Dec;82(12):1527-1537. doi: 10.1136/ard-2023-224449. Epub 2023 Sep 11. Ann Rheum Dis. 2023. PMID: 37696589 Free PMC article. Clinical Trial.
Laparoscopic bariatric surgery.
Schirmer B, Watts SH. Schirmer B, et al. Among authors: watts sh. Surg Endosc. 2003 Dec;17(12):1875-8. doi: 10.1007/s00464-003-0044-3. Epub 2003 Dec 1. Surg Endosc. 2003. PMID: 14648187 No abstract available.
Multiscale QM/MM modelling of catalytic systems with ChemShell.
Lu Y, Sen K, Yong C, Gunn DSD, Purton JA, Guan J, Desmoutier A, Abdul Nasir J, Zhang X, Zhu L, Hou Q, Jackson-Masters J, Watts S, Hanson R, Thomas HN, Jayawardena O, Logsdail AJ, Woodley SM, Senn HM, Sherwood P, Catlow CRA, Sokol AA, Keal TW. Lu Y, et al. Among authors: watts s. Phys Chem Chem Phys. 2023 Aug 23;25(33):21816-21835. doi: 10.1039/d3cp00648d. Phys Chem Chem Phys. 2023. PMID: 37097706 Free article. Review.
Demonstrating Spatial Resolution.
Watts S. Watts S. Radiol Technol. 2019 Sep;91(1):69-70. Radiol Technol. 2019. PMID: 31471478 No abstract available.
1,139 results